Workflow
Xencor(XNCR)
icon
Search documents
Xencor(XNCR) - 2019 Q1 - Quarterly Report
2019-05-09 21:01
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-36182 Xencor, Inc. (Exact Name of Registrant as Specified in its Charter) (State or Other Jurisdiction of Incorporation or Organization) 111 West ...
Xencor(XNCR) - 2018 Q4 - Annual Report
2019-02-26 15:22
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10‑K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the fiscal year ended December 31, 2018 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001‑36182 Xencor, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation or Organizati ...
Xencor(XNCR) - 2018 Q4 - Earnings Call Transcript
2019-02-26 03:03
Xencor, Inc. (NASDAQ:XNCR) Q4 2018 Results Earnings Conference Call February 25, 2019 4:30 PM ET Company Participants Charles Liles - Associate Director and Head of Corporate Communications and IR Bassil Dahiyat - President and CEO Paul Foster - SVP and Chief Medical Officer John Kuch - SVP, Finance and CFO Conference Call Participants Ted Tenthoff - Piper Jaffray Alethia Young - Cantor Fitzgerald Arlinda Lee - CG Jonathan Chang - CVB Leerink Jackson Harvey - Nomura David Nierengarten - Wedbush Securities O ...